[SY9] シンポジウム 9 「Data Science for Virology: From Models to Real-World Impact」

15:50 〜 16:15

[SY9-2] Optimal virologic endpoint selection allows efficient, rapid and small early phase trials for respiratory virus targeting antiviral agents

*Joshua T. Schiffer^1,2, Chenhui Ma¹ (1. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, 2. Department of Medicine, University of Washington, Seattle)

閲覧にはパスワードが必要です